Evaluating clinical reason and rationale for not delivering reperfusion therapy in ST elevation myocardial infarction patients: Insights from a comprehensive cohort.

@article{Welsh2016EvaluatingCR,
  title={Evaluating clinical reason and rationale for not delivering reperfusion therapy in ST elevation myocardial infarction patients: Insights from a comprehensive cohort.},
  author={Robert C. Welsh and Jessica Deckert-Sookram and Sunil M. Sookram and Shelley Valaire and Neil Brass},
  journal={International journal of cardiology},
  year={2016},
  volume={216},
  pages={99-103}
}
BACKGROUND In ST elevation myocardial infarction (STEMI), reperfusion therapy is lifesaving but is not delivered in approximately one quarter of patients. To address this care gap, we reviewed all STEMI patients that did not receive reperfusion to identify patient characteristics, in-hospital outcomes and the clinical reason or rationale for withholding reperfusion therapy. METHODS A prospective chart review identified a consecutive cohort of STEMI patients over one-year within a defined… CONTINUE READING